autoimmune disease

Roche looks to a Flagship startup in search of new immune drugs
BioPharma Dive
Wed, 04/23/25 - 09:50 am
Roche
Repertoire Immune Medicines
Genentech
autoimmune disease
Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy
BioPharma Dive
Thu, 03/27/25 - 11:15 am
Nkarta
layoffs
cell therapy
autoimmune disease
Immunovant claims study success for immune disease drug but holds off on submission
BioPharma Dive
Wed, 03/19/25 - 11:10 pm
Immunovant
autoimmune disease
batoclimab
Biotech Maxion Therapeutics secures $72M Series A
Tech.eu
Mon, 03/17/25 - 10:05 am
Maxion Therapeutics
funding
chronic pain
autoimmune disease
cardiovascular disease
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
MSN/Reuters
Fri, 02/21/25 - 11:18 am
Teva Pharmaceutical
Alvotech
biosimilars
Stelara
autoimmune disease
Selarsdi
Crohn's Disease
ulcerative colitis
plaque psoriasis
Ouro makes debut with $120m for autoimmune disease TCEs
Pharmaphorum
Fri, 01/10/25 - 11:20 am
Ouro Medicines
autoimmune disease
funding
Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M
BioSpace
Tue, 12/3/24 - 11:23 am
Roche
Cour Pharmaceuticals
Genentech
autoimmune disease
immune tolerance platform
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Yahoo/Benzinga
Tue, 11/19/24 - 07:09 pm
Bristol Myers Squibb
ACR
clinical trials
autoimmune disease
More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce
Fierce Pharma
Thu, 11/7/24 - 11:52 pm
Aurinia Pharmaceuticals
autoimmune disease
layoffs
restructuringhttps://www.fiercepharma.com/pharma/more-turbulence-aurinia-autoimmune-drugmaker-lays-45-workforce
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
PR Newswire
Thu, 11/7/24 - 11:23 am
Aditum Bio
Leads Biolabs
Oblenio Bio
Joe Jimenez
autoimmune disease
T-cell engager
Sana to lay off staff, deepen autoimmune focus in latest retrenchment
BioPharma Dive
Tue, 11/5/24 - 09:58 am
Sana Biotechnology
layoffs
autoimmune disease
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
BioSpace
Fri, 10/4/24 - 09:17 am
Sanofi
Recordati
autoimmune disease
cold agglutinin disease
Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease
BioPharma Dive
Mon, 09/9/24 - 10:56 am
Candid Therapeutics
T-cell engager
RayzeBio
autoimmune disease
funding
Merck bets $700M on an antibody drug’s potential in immune diseases
BioPharma Dive
Fri, 08/9/24 - 11:57 am
Merck
autoimmune disease
Curon Biopharmaceutical
China
bispecific antibodies
Cue Biopharma downsizes to focus on autoimmune pipeline
Clinical Trials Arena
Fri, 07/26/24 - 11:09 am
Cue Biopharma
autoimmune disease
layoffs
J&J vets burst into biotech with $165M Third Arc series A
Fierce Biotech
Tue, 07/23/24 - 11:22 am
JNJ
Third Arc Bio
funding
solid tumors
autoimmune disease
Artiva prices $167M IPO, riding optimism for autoimmune cell therapy
BioPharma Dive
Fri, 07/19/24 - 11:43 am
Artiva
IPOs
autoimmune disease
Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder
Pharma Voice
Fri, 07/19/24 - 11:39 am
Kyverna Therapeutics
CAR-T
stiff person syndrome
autoimmune disease
Artiva sets out $135M IPO plans to push NK cell therapy through trials
Fierce Biotech
Mon, 07/15/24 - 09:58 am
Artiva
IPO
autoimmune disease
natural killer cell therapies
SciRhom pulls in $70M for a new type of immune disease drug
BioPharma Dive
Tue, 07/9/24 - 09:12 pm
SciRhom
autoimmune disease
funding

Pages